Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FloraSeal is a sterile, liquid microbial sealant designed for use in surgical settings to minimize the risk of surgical site infections. Developed by Adhezion Biomedical (now part of H.B. Fuller), the product is a cyanoacrylate-based film-forming agent that utilizes OctylFlex Technology. It is applied topically to the skin after standard preoperative preparation but before the surgical incision is made. Once applied, it dries into a flexible, waterproof film that acts as a physical barrier, preventing the migration of skin flora, including MRSA, into the surgical wound. It typically remains on the skin for 5 to 7 days and is classified as a medical device rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FloraSeal.